KR0165003B1 - 2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischem ic agents - Google Patents

2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischem ic agents Download PDF

Info

Publication number
KR0165003B1
KR0165003B1 KR1019940700124A KR19940700124A KR0165003B1 KR 0165003 B1 KR0165003 B1 KR 0165003B1 KR 1019940700124 A KR1019940700124 A KR 1019940700124A KR 19940700124 A KR19940700124 A KR 19940700124A KR 0165003 B1 KR0165003 B1 KR 0165003B1
Authority
KR
South Korea
Prior art keywords
antiischem
hydroxypiperidino
agents
alkanol derivatives
alkanol
Prior art date
Application number
KR1019940700124A
Other languages
English (en)
Inventor
Willard Mckowan Wellch Jr
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of KR0165003B1 publication Critical patent/KR0165003B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1019940700124A 1991-07-17 1994-01-15 2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischem ic agents KR0165003B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73157791A 1991-07-17 1991-07-17
PCT/US1992/004973 WO1993002052A1 (en) 1991-07-17 1992-06-19 2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agents

Publications (1)

Publication Number Publication Date
KR0165003B1 true KR0165003B1 (en) 1999-01-15

Family

ID=24940103

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940700124A KR0165003B1 (en) 1991-07-17 1994-01-15 2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischem ic agents

Country Status (22)

Country Link
EP (1) EP0594729A1 (ko)
JP (1) JP2571904B2 (ko)
KR (1) KR0165003B1 (ko)
CN (1) CN1043759C (ko)
AU (1) AU655840B2 (ko)
BR (1) BR9206272A (ko)
CA (1) CA2113568A1 (ko)
CZ (1) CZ284133B6 (ko)
EG (1) EG20048A (ko)
FI (2) FI940192A (ko)
HU (1) HUT70528A (ko)
IE (1) IE922311A1 (ko)
IL (1) IL102473A (ko)
MX (1) MX9204190A (ko)
NO (1) NO180445C (ko)
NZ (1) NZ243580A (ko)
PL (1) PL169884B1 (ko)
PT (1) PT100689B (ko)
RU (1) RU2065859C1 (ko)
TW (1) TW201732B (ko)
WO (1) WO1993002052A1 (ko)
ZA (1) ZA925306B (ko)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5436255A (en) * 1992-07-23 1995-07-25 Pfizer Inc. Method of treating diseases susceptable to treatment by blocking NMDA-receptors
BR9307331A (pt) * 1992-10-30 1999-05-25 Pfizer Compostos neuroprotetores 3,4-dihidro-2(1ho-quinolona
US5498610A (en) * 1992-11-06 1996-03-12 Pfizer Inc. Neuroprotective indolone and related derivatives
ZA9610741B (en) 1995-12-22 1997-06-24 Warner Lambert Co 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ZA9610736B (en) * 1995-12-22 1997-06-27 Warner Lambert Co 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists
ZA9610738B (en) 1995-12-22 1997-06-24 Warner Lambert Co Subtype selective nmda receptor ligands and the use thereof
ZA9610745B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists
WO2000061558A1 (fr) * 1999-04-09 2000-10-19 Mochida Pharmaceutical Co., Ltd. Remedes pour douleurs neurogenes
US6316474B1 (en) 1999-10-29 2001-11-13 Merck & Co., Inc. 2-benzyl and 2-heteroaryl benzimidazole NMDA/NR2B antagonists
US6432976B1 (en) 1999-10-29 2002-08-13 Merck & Co., Inc. 8-aza-bicyclo[3.2.1]octane NMDA/NR2B antagonists
US6369076B1 (en) 1999-10-29 2002-04-09 Merck & Co. Inc. 5-benzyl-octahydroindole and 6-benzyl-decahydroquinoline NMDA/NR2B antagonists
US6489477B1 (en) 1999-10-29 2002-12-03 Merck & Co., Inc. 2-aza-bicyclo[2.2.2]octane NMDA/NR2B antigonists
US6380205B1 (en) 1999-10-29 2002-04-30 Merck & Co., Inc. 2-cyclohexyl quinazoline NMDA/NR2B antagonists
US6476041B1 (en) 1999-10-29 2002-11-05 Merck & Co., Inc. 1,4 substituted piperidinyl NMDA/NR2B antagonists
CA2386441A1 (en) 1999-10-29 2001-05-03 Merck Sharp & Dohme Limited Method to treat pain utilizing benzimidazole nmda/nr2b antagonists
US6291499B1 (en) 1999-10-29 2001-09-18 Merck & Co., Inc. 2-cyclohexyl benzimidazole NMDA/NR2B antagonists
US6495561B2 (en) 1999-10-29 2002-12-17 Merck & Co., Inc. 2-cyclohexyl imidazopyridine NMDA/NR2B antagonists
SI1379520T1 (sl) 2001-02-23 2006-08-31 Merck & Co Inc N-substituirani nonaril-heterociklicni NMDA/NR2B antagonisti
WO2002080928A1 (en) 2001-04-03 2002-10-17 Merck & Co., Inc. N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists
CA2507509A1 (en) 2002-11-25 2004-06-10 Mochida Pharmaceutical Co., Ltd. Therapeutic agent for respiratory disease containing 4-hydroxypiperidine derivative as active ingredient
JP2007508288A (ja) * 2003-10-08 2007-04-05 ファイザー株式会社 縮合ラクタム化合物
TWI409289B (zh) 2010-09-02 2013-09-21 Taiwan Union Technology Corp 由氮氧雜環化合物所製得之聚合物之穩態溶液及其製法與用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH17194A (en) * 1980-03-06 1984-06-19 Otsuka Pharma Co Ltd Novel carbostyril derivatives,and pharmaceutical composition containing the same
FR2546166B1 (fr) * 1983-05-19 1985-10-25 Synthelabo Enantiomeres du erythro (benzyl-4 piperidino)-2 (hydroxy-4 ou benzyloxy-4 phenyl)-1 propanol, leur preparation et leur application en therapeutique
FR2640266B2 (fr) * 1988-07-12 1992-07-10 Synthelabo Derives de (hydroxy-1 piperidinyl-2 alkyl) indolones-2, quinoleinones-2, benzo(b)azepinones-2 et benzimidazolones-2, leur preparation et leur application en therapeutique
EP0398578B1 (en) * 1989-05-17 1997-03-12 Pfizer Inc. 2-piperidino-1-alkanol derivatives as antiischemic agents
CA2080475C (en) * 1990-05-10 2001-04-17 Bertrand Leo Chenard Neuroprotective indolone and related derivatives

Also Published As

Publication number Publication date
ZA925306B (en) 1994-01-17
IL102473A0 (en) 1993-01-14
NO940144D0 (no) 1994-01-14
CN1043759C (zh) 1999-06-23
JPH06504293A (ja) 1994-05-19
TW201732B (ko) 1993-03-11
NO940144L (no) 1994-01-14
IL102473A (en) 1997-07-13
FI940192A0 (fi) 1994-01-14
AU655840B2 (en) 1995-01-12
EG20048A (en) 1997-03-27
BR9206272A (pt) 1995-04-11
CN1068566A (zh) 1993-02-03
FI940192A (fi) 1994-01-14
IE922311A1 (en) 1993-01-27
EP0594729A1 (en) 1994-05-04
NZ243580A (en) 1994-10-26
PL169884B1 (pl) 1996-09-30
MX9204190A (es) 1993-01-01
RU2065859C1 (ru) 1996-08-27
FI981956A (fi) 1998-09-11
AU2322592A (en) 1993-02-23
PT100689B (pt) 1999-06-30
CZ400892A3 (en) 1994-03-16
NO180445C (no) 1997-04-23
CA2113568A1 (en) 1993-02-04
CZ284133B6 (cs) 1998-08-12
PT100689A (pt) 1993-10-29
WO1993002052A1 (en) 1993-02-04
NO180445B (no) 1997-01-13
HU9400136D0 (en) 1994-05-30
JP2571904B2 (ja) 1997-01-16
HUT70528A (en) 1995-10-30
FI981956A0 (fi) 1998-09-11

Similar Documents

Publication Publication Date Title
KR0165003B1 (en) 2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischem ic agents
SG48108A1 (en) Tocotrienols and tocotrienol-like compounds and methods for their use
EP0586537A4 (en) Substituted n-carboxyalkylpeptidyl derivatives as antidegenerative active agents
ZA924974B (en) Ophthalmic compositions
GB9103454D0 (en) Therapeutic agents
GB9104136D0 (en) Therapeutic agents
EP0511792A3 (en) Pyridoprimidine derivatives as antineoplastic agents
GB9320940D0 (en) Substituted n-carboxyalkylpeptidyl derivatives as antidegenerative agents
GB9111376D0 (en) Therapeutic agents
EP0578560A3 (en) Amido-alcohol derivatives as psychotropic agents
HU9203726D0 (en) 2-(heteroaryl-oxi-phenoxi)-alkyl-sulphonates having herbicidal effect
CA68940S (en) Goggles
EG19704A (en) Therapeutic agents
GB9127354D0 (en) Agents for therapy
KR950022316U (ko) 이노베이션의 ic용 튜브공급장치
PL289363A1 (en) Flocculating agent
IE901154L (en) Thioformamide derivatives
ITGE910039V0 (it) "boa segna-sub"
ITMI911049A1 (it) Composizione oftalmica
IL103999A0 (en) 5-isoquinolinesulfonamide derivatives as protein kinase inhibiting agents
GB9115107D0 (en) Pharmaceutical agents
GB9110438D0 (en) Therapeutic agents
GB9109816D0 (en) Therapeutic agents
GB9107625D0 (en) Therapeutic agents
GB9107439D0 (en) Therapeutic agents

Legal Events

Date Code Title Description
A201 Request for examination
AMND Amendment
E902 Notification of reason for refusal
AMND Amendment
E601 Decision to refuse application
J201 Request for trial against refusal decision
B701 Decision to grant
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee